GASTROESOPHAGEAL REFLUX DISEASE AND ATRIAL FIBRILLATION: CAUSE AND EFFECT RELATIONSHIPS, TREATMENT PROBLEMS

DOI: https://doi.org/10.29296/25877305-2023-06-13
Issue: 
6
Year: 
2023

I. Sopenko; P. Semenikhina; Professor A. Kotlyarov, MD; D. Maryevskaya
Obninsk Institute for Nuclear Power Engineering

This article examines the causal relationship between gastroesophageal reflux disease (GERD) and atrial fibrillation (AF). The problems of treatment of this comorbid pathology are highlighted. In some studies, antireflux therapy for GERD demonstrates effective antiarrhythmic activity against AF, in others it indicates the possible development of the opposite - a proarrhythmic effect. Treatment of AF with catheter ablation can exacerbate GERD and cause severe complications. The obtained results indicate that large prospective studies are required for a more detailed understanding of the features of the interaction between GERD and AF, as well as the tactics of managing patients with this comorbid pathology.
Keywords: 
cardiology
gastroenterology
atrial fibrillation
gastroesophageal reflux disease
proton pump inhibitors
radiofrequency ablation.

References: 
  1. Антропова О.Н., Пырикова Н.В., Осипова И.В. Фибрилляция предсердий и гастроэзофагеальная болезнь: механизмы взаимосвязи, подходы к лечению. Российский кардиологический журнал. 2019; 24 (7): 103–9 [Antropova O.N., Pyrikova N.V., Osipova I.V. Atrial fibrillation and gastrooesophageal reflux disease: association mechanisms, treatment approaches. Russian Journal of Cardiology. 2019; 24 (7): 103–9 (in Russ.)]. DOI: 10.15829/1560-4071-2019-7-103-109
  2. Затонская Е.В., Матюшин Г.В., Гоголашвили Н.Г. Распространенность и клиническое значение нарушений ритма сердца. Рациональная фармакотерапия в кардиологии. 2017; 13 (3): 403–8 [Zatonskaya E.V., Matyushin G.V., Gogolashvili N.G. The prevalence and clinical significance of cardiac arrhythmias. Rational Pharmacotherapy in Cardiology. 2017; 13 (3): 403–8 (in Russ.)]. DOI: 10.20996/1819-6446-2017-13-3-403-408
  3. Шаповалова М.М. Гастроэзофагеальная рефлюксная болезнь и нейрогенные аритмии сердца (обзор литературы). Молодой ученый. 2014; 5: 165–7 [Shapovalova M.M. Gastroesophageal reflux disease and neurogenic cardiac arrhythmias (literature review). Young scientist. 2014; 5: 165–7 (in Russ.)].
  4. Блинова В.В., Богданова Т.М., Семенова В.А. и др. Нарушения сердечного ритма и проводимости при заболеваниях пищевода и желудочно-кишечного тракта. Современные проблемы науки и образования. 2020; 6: 207 [Blinova V.V., Bogdanova T.M., Semenova V.A. et al. Disorders of the heart rhythm and conduction in diseases of the esophagus and gastrointestinal tract. Modern problems of science and education. 2020; 6: 207 (in Russ.)].
  5. Маев И.В., Казюлин А.Н., Юренев Г.Л. Кардиальный синдром при гастроэзофагеальной рефлюксной болезни: проявления, частота и причины возникновения, способы устранения. Эффективная фармакотерапия. 2014; 25: 8–17 [Maev I.V., Kazyulin A.N., Yurenev G.L. Cardiac syndrome in gastroesophageal reflux disease: manifestations, frequency and causes, methods of elimination. Effective pharmacotherapy. 2014; 25: 8–17 (in Russ.)].
  6. Еремина Е.Ю., Зверева С.И., Рябова Е.А. Значение показателей вариабельности сердечного ритма у больных гастроэзофагеальной рефлюксной болезнью. Медицинский алфавит. 2017; 2 (19): 32–4 [Eremina E.Yu., Zvereva S.I., Ryabova E.I. Values of heart rate variability in patients with gastroesophageal reflux disease. Medical alphabet. 2017; 2 (19): 32–4 (in Russ.)].
  7. Linz D., Hohl V., Vollmar J. et al. Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction. Europace. 2017; 19: 16–20. DOI: 10.1093/europace/euw092
  8. Костюкевич О.И., Рылова А.К., Рылова Н.В. и др. Внепищеводные маски гастроэзофагеальной рефлюксной болезни. РМЖ. Медицинское обозрение. 2018; 2 (7-2): 76–81 [Kostyukevich O.I., Rilova A.K., Rilova N.V. et al. Extraesophageal masks of gastroesophageal reflux disease. RMJ. Medical Review. 2018; 2 (7-2): 76–8 (in Russ.)].
  9. Maruyama T., Fukata M., Akashi K. Association of atrial fibrillation and gastroesophageal reflux disease: Natural and therapeutic linkage of the two common diseases. J Arrhythm. 2018; 35 (1): 43–51. DOI: 10.1002/joa3.12125
  10. Cuomo R., De Giorgi F., Adinolfi L. et al. Oesophageal acid exposure and altered neurocardiac function in patients with GERD and idiopathic cardiac dysrhythmias. Aliment Pharmacol Ther. 2006; 24 (2): 361–70. DOI: 10.1111/j.1365-2036.2006.02987.x
  11. Gerson L.B., Friday K., Triadafilopoulos G. Potential relationship between gastroesophageal reflux disease and atrial arrhythmias. J Clin Gastroenterol. 2006; 40 (9): 828–32. DOI: 10.1097/01.mcg.0000225571.42890.a5 [Erratum in: J Clin Gastroenterol. 2006; 40 (10): 958. Gerson, Lauren (corrected to Gerson, Lauren B.)].
  12. Chen K.P., Lee J., Mark R.G. et al. Proton Pump Inhibitor Use Is Not Associated With Cardiac Arrhythmia in Critically Ill Patients. J Clin Pharmacol. 2015; 55 (7): 774–9. DOI: 10.1002/jcph.479
  13. Marcus G.M., Smith L.M., Scheinman M.M. et al. Proton pump inhibitors are associated with focal arrhythmias. J Innovations Card Rhythm Manage. 2010; 1: 85–9. DOI: 10.19102/icrm.2010.011206
  14. Huang C.C., Chan W.L., Luo J.C. et al. Gastroesophageal reflux disease and atrial fibrillation: a nationwide population-based study. PLoS One. 2012; 7: e47575. DOI: 10.1371/journal.pone.0047575
  15. Odashiro K., Yasuda S., Yokoyama T. et al. Prevalence of gastroesophageal reflux disorder in arrhythmic patients and adjunctive effects of proton pump inhibitors on comorbid atrial fibrillation. Int J Basic Clin Pharmacol. 2015; 4: 644–50. DOI: 10.18203/2319-2003.ijbcp20150365
  16. Цапкова В.А., Захаров Ю.В., Кондрючая Н.С. и др. Фибрилляция предсердий и гастроэзофагеальная рефлюксная болезнь: современные аспекты фармакотерапии коморбидной патологии. Лекарственный вестник. 2021; 15 (1): 46–56 [Tsapkova V.A., Zakharov Yu.V., Kondryuchaya N.S. et al. Atrial fibrillation and gastroesophageal reflux disease: modern aspects of pharmacotherapy of comorbid pathology. Medicinal Bulletin. 2021; 15 (1): 46–56 (in Russ.)].
  17. Ивашкин В.Т., Маев И.В., Трухманов А.С. и др. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению гастроэзофагеальной рефлюксной болезни. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020; 30 (4): 70–97 [Ivashkin V.T., Maev I.V., Trukhmanov A.S. et al. Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020; 30 (4): 70–97 (in Russ.)]. DOI: 10.22416/1382-4376-2020-30-4-70-97
  18. Маев И.В., Андреев Д.Н., Дичева Д.Т. Гастроэзофагеальная рефлюксная болезнь: от патогенеза к терапевтическим аспектам. Consilium Medicum. 2013; 15 (8): 30–4 [Maev I.V., Andreev D.N., Dicheva D.T. Gastroesophageal reflux disease: from pathogenesis to therapeutic aspects. Consilium Medicum. 2013; 15 (8): 30–4 (in Russ.)].
  19. Reddy Y.M., Singh D., Nagarajan D. et al. Atrial fibrillation ablation in patients with gastroesophageal reflux disease or irritable bowel syndrome-the heart to gut connection! J Interv Card Electrophysiol. 2013; 37: 259–65. DOI: 10.1007/s10840-013-9807-5
  20. Knopp H., Halm U., Lamberts R. Incidental and ablation-induced findings during upper gastrointestinal endoscopy in patients after ablation of atrial fibrillation: a retrospective study of 425 patients. Heart Rhythm. 2014; 11: 574–8. DOI: 10.1016/j.hrthm.2014.01.010
  21. Tolone S., Savarino E., Docimo L. Radiofrequency Catheter Ablation for Atrial Fibrillation Elicited "Jackhammer Esophagus": A New Complication Due to Vagal Nerve Stimulation? J Neurogastroenterol Motil. 2015; 21 (4): 612–5. DOI: 10.5056/jnm15034
  22. Chavez P.., Messerli FH., Dominguez A.C. et al. Atrioesophageal fistula following ablation procedures for atrial fibrillation: systematic review of case reports. Open Heart. 2015; 2 (1): e000257. DOI: 10.1136/openhrt-2015-000257
  23. Orosey M., Garg L., Agrawal S. et al. Atrioesophageal fistula following radiofrequency catheter ablation of atrial fibrillation. Rev Cardiovasc Med. 2017; 18: 115–22. DOI: 10.3909/ricm0883
  24. Han H.C., Ha F.J., Sanders P. et al. Atrioesophageal fistula: clinical presentation, procedural characteristics, diagnostic investigations, and treatment outcomes. Circ Arrhythm Electrophysiol. 2017; 10: e005579. DOI: 10.1161/circep.117.005579
  25. Эффективность длительного приема дабигатрана у больных с фибрилляцией предсердий: результаты многоцентрового обсервационного исследования RELY-ABLE. Доказательная кардиология (электронная версия). 2013; 3: 21–5 [Long-term efficacy of dabigatran in patients with atrial fibrillation: results of the RELY-ABLE multicentre observational study. Evidence-based cardiology (electronic version). 2013; 3: 21–5 (in Russ.)].